Autotaxin in liver fibrosis

被引：58

作者：

Ikeda, Hitoshi ^{[1
]}

Yatomi, Yutaka ^{[1
]}

机构：

[1] Univ Tokyo, Grad Sch Med, Dept Clin Lab Med, Bunkyo Ku, Tokyo 1138655, Japan

来源：

CLINICA CHIMICA ACTA | 2012年 / 413卷 / 23-24期

关键词：

Autotaxin; Lysophospholipase D; Liver fibrosis; Lysophosphatidic acid; HEPATIC STELLATE CELLS; PLASMA LYSOPHOSPHATIDIC ACID; HUMAN HEPATOCELLULAR-CARCINOMA; SINUSOIDAL ENDOTHELIAL-CELLS; HUMAN SERUM SAMPLES; LYSOPHOSPHOLIPASE-D; GLIOBLASTOMA-MULTIFORME; RHO-KINASE; RAT; EXPRESSION;

D O I：

10.1016/j.cca.2012.07.014

中图分类号：

R446 [实验室诊断]; R-33 [实验医学、医学实验];

学科分类号：

1001 ;

摘要：

Autotaxin (ATX) hydrolyzes lysophosphatidylcholine to produce lysophosphatidic acid (LPA), a multi-functional bioactive lipid mediator. ATX is a major determinant of LPA levels in the blood, and the pathophysiological functions of ATX are thought to be largely attributed to its ability to produce LPA. Liver fibrosis is one of the rare disorders exhibiting the increased ATX and LPA levels in the blood. This review summarizes the recent findings on the relation between ATX or LPA and liver fibrosis, the usefulness of serum ATX levels to predict the stages of liver fibrosis, and speculated roles of increased serum ATX and plasma LPA levels in liver fibrosis. (C) 2012 Elsevier B.V. All rights reserved.

引用

页码：1817 / 1821

页数：5

共 56 条

[1]

ABDELAZIZ G, 1990, AM J PATHOL, V137, P1333

[2] Boronic acid-based inhibitor of autotaxin reveals rapid turnover of LPA in the circulation [J].

Albers, Harald M. H. G. ;

Dong, Anping ;

van Meeteren, Laurens A. ;

Egan, David A. ;

Sunkara, Manjula ;

van Tilburg, Erica W. ;

Schuurman, Karianne ;

van Tellingen, Olaf ;

Morris, Andrew J. ;

Smyth, Susan S. ;

Moolenaar, Wouter H. ;

Ovaa, Huib .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2010, 107 (16) :7257-7262

[3] Serum lysophosphatidic acid is produced through diverse phospholipase pathways [J].

Aoki, J ;

Taira, A ;

Takanezawa, Y ;

Kishi, Y ;

Hama, K ;

Kishimoto, T ;

Mizuno, K ;

Saku, K ;

Taguchi, R ;

Arai, H .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (50) :48737-48744

[4] Cooperation of fibronectin with lysophosphatidic acid induces motility and transcellular migration of rat ascites hepatoma cells [J].

Ayaki, M ;

Mukai, M ;

Imamura, F ;

Iwasaki, T ;

Mammoto, T ;

Shinkai, K ;

Nakamura, H ;

Akedo, H .

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 2000, 1495 (01) :40-50

[5] Plasma lysophosphatidic acid concentration and ovarian cancer [J].

Baker, DL ;

Morrison, P ;

Miller, B ;

Riely, CA ;

Tolley, B ;

Westermann, AM ;

Bonfrer, JMG ;

Bais, E ;

Moolenaar, WH ;

Tigyi, G .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 287 (23) :3081-3082

[6] Induction of autotaxin by the Epstein-Barr virus promotes the growth and survival of Hodgkin lymphoma cells [J].

Baumforth, KRN ;

Flavell, JR ;

Reynolds, GM ;

Davies, G ;

Pettit, TR ;

Wei, WB ;

Morgan, S ;

Stankovic, T ;

Kishi, Y ;

Arai, H ;

Nowakova, M ;

Pratt, G ;

Aoki, J ;

Wakelam, MJO ;

Young, LS ;

Murray, PG .

BLOOD, 2005, 106 (06) :2138-2146

[7] Biological roles of lysophospholipid receptors revealed by genetic null mice: An update [J].

Choi, Ji Woong ;

Lee, Chang-Wook ;

Chun, Jerold .

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS, 2008, 1781 (09) :531-539

[8] LPA Receptors: Subtypes and Biological Actions [J].

Choi, Ji Woong ;

Herr, Deron R. ;

Noguchi, Kyoko ;

Yung, Yun C. ;

Lee, Charig-Wook ;

Mutoh, Tetsuji ;

Lin, Mu-En ;

Teo, Siew T. ;

Park, Kristine E. ;

Mosley, Alycia N. ;

Chun, Jerold .

ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 2010, 50 :157-186

[9] Genetic basis of human breast cancer metastasis [J].

Debies, MT ;

Welch, DR .

JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA, 2001, 6 (04) :441-451

[10] Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury [J].

Friedman, SL .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (04) :2247-2250

← 1 2 3 4 5 6 →